Patient Registry Software Market
Market Insights on Patient Registry Software covering sales outlook, demand forecast & up-to-date key trends
Patient Registry Software Market by Type, Disease Area, End-User & Region - Forecast 2022 - 2032
Patient Registry Software Market Outlook (2022-2032)
[307 Pages Report] Flourishing at a CAGR of 8.8% from 2022 to 2032, the global patient registry software market is expected to procure US$ 4.4 Billion by 2032, against US$ 1.9 Billion in 2022. Increased revenue can be attributed to the increasing prevalence of chronic diseases and the rising geriatric population.
“Growing incidences of chronic diseases across the globe is expected to drive the patient registry software market in the forecast period. With the growing cases of cancer, diabetes, and cardiovascular diseases, among others, there has been a significant rise in demand for EHRs, which will benefit the market in the forecast period.”
Increasing application of electronic health records and growing usage of stored data for post-marketing surveillance and implementation of favorable government initiatives are expected to play a significant role in strengthening the market in the forecast period. Also, with rising pressure to lessen costs and increasing access to social media and mobile technologies, the healthcare sector is experiencing a significant transformation, which is expected to benefit the patient registry software market in the forecast period.
|
Attributes |
Details |
|
Patient Registry Software Market CAGR (2022-2032) |
8.8% |
|
Patient Registry Software Market Size (2022) |
US$ 1.9 Billion |
|
Patient Registry Software Market (2032) |
US$ 4.4 Billion |
Increasing investment in clinical trials by various biotechnological and pharmaceutical enterprises is anticipated to offer significant opportunities to the market. In June 2019, CloudPWR announced a strategic partnership with Accela. The initiative will assist in tapping the volume-based consumption of medical cannabis to reduce misuse.
Let us know your requirement to get
100% FREE customization
What are the Major Factors Fuelling the Global Patient Registry Software Market?
Increasing adoption of EHRs in the healthcare sector is expected to be the key factor benefitting the global patient registry software market during the forecast period. Growing initiatives by the various government to implement strategies to lessen regulatory and administrative responsibilities on healthcare providers is expected to play a salient role in driving demand for EHRs in the healthcare sector thereby, benefitting the patient registry software market.
For instance, on December 13, 2016, the U.S introduced Cures Act, which aims to enhance medical product development and offer innovative and advanced medical technology. Such initiatives are expected to drive the demand for EHRs, thus, benefitting the market during the assessment period.
With the incorporation of AI into electronic health record solutions, the market is expected to experience a notable expansion. Various players are aiming to incorporate the technology in the EHRs through voice recognition capabilities.
For example, a physician can access a voice-based HER solution to analyze a patient’s last recorded medical reports. In October 2019, various scripts along with Northwell Health inked an agreement to produce the next-generation electronic health record. The initiative is expected to support massive revenue generation, thereby, fuelling the market expansion in the coming time.
Over the last few years, there has been a rise in demand for EHRs in various countries. This can be attributed to the growing demand for robust health information technology, which is important to achieve fine quality services at affordable prices.
The increasing application of EHRs in the healthcare sector helps in result management, analyze health information and data, and decision supports, which is anticipated to strengthen the market in the forecast period.
What are the Emerging Opportunities in the Patient Registry Software Market?
The emergence of cloud-based EHR software is expected to offer significant market opportunities during the assessment period. Such solutions offer more advanced and developed approaches. Moreover, the installation expenses for the system are cheaper than the client server-based systems. Also, such methods eliminate the requirement for in-house maintenance, which is expected to offer significant opportunities to the patient registry software market.
Other benefits offered, such as; low-cost maintenance, low licensing, cheaper start-up cost, and wider accessibility are other salient factors that can offer various avenues of opportunities to the market in the forecast period. Moreover, these solutions do not demand any major capital investment for hardware and offer swift data transfer between enterprises. Owing to such benefits, the demand for cloud-based software is expected to witness considerable opportunities in the coming time.
In April 2020, Allscripts launched a COVID-19 package of solutions for healthcare institutions. The Allscripts Hospital Management Package offers a series of COVID-19 workflows that recognizes disease-specific demands within SunriseTM EHR, Allscripts Care Director, and Paragon EHR.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWhat are the Factors the Global Patient Registry Software Uptake?
Concerns associated with data privacy and security are expected to impact the market negatively in the forecast period. The breach of data can result in the exposure of confidential details of a large number of patients. Moreover, there have been various cases of data breaches.
About one-third of data breaches lead to medical identity theft, principally because of a lack of internal control over patient information, conventional policies, and a dearth of personnel expertise. As per the Identity Theft Resource Center, the U.S recorded about 1.473 breaches in 2019, a rise of 17% against 2018.
Moreover, there has been a reluctance in adopting modern solutions and enterprises yet rely on paper paper-based solutions. Small and rural areas continue to use conventional paper-based registry methods. Also, several hospitals do not encourage the application of such approaches owing to the lack of expertise and various costs included in the implementation of such software.
In April 2022, the GHT Coeur Grand Est. Hospitals, a Northeast France-based healthcare institute, had to disconnect all outgoing and incoming Internet connections after they suffered from a cyberattack that resulted in the theft of administrative and patient data.
Comparative View of Adjacent Patient Registry Software Markets
Global Patient Registry Software Market:
|
Attributes |
Global Patient Registry Software Market |
|
CAGR (2022-2032) |
8.8% |
|
Market Value (2032) |
US$ 4.4 Billion |
|
Growth Factor |
Growing initiatives by the various government to implement strategies to lessen regulatory and administrative responsibilities on healthcare providers |
|
Opportunity |
Emergence of cloud-based EHR software is expected to offer significant market opportunities during the assessment period |
Medical Software Market:
|
Attributes |
Medical Software Market |
|
CAGR (2022-2032) |
7% |
|
Market Value (2032) |
US$ 7.05 Billion |
|
Growth Factor |
Increasing application of electronic health records to distribute, store, and manage patient health information through medical images is expected to drive the demand for efficient medical software in the assessment period. |
|
Opportunity |
Integration of machine learning and AI in the healthcare sector is anticipated to various avenues of opportunities to the market in the assessment period. |
Global EHR Market:
|
Attributes |
Global EHR Market |
|
CAGR (2022-2032) |
5% |
|
Market Value (2032) |
US$ 45.6 Billion |
|
Growth Factor |
Growing application of electronic health records in the administrative sector and healthcare financing among others are expected to drive the global sales for EHR in the assessment period. |
|
Opportunity |
The incorporation of AI and voice recognition with EHR is expected to offer significant opportunities for expansion in the forecast period |
An unified Market Research Subscription Platform, built for today’s disparate research needs.
Segmental Overview of the Patient Registry Software Market
Based on type, the global patient registry software market can be segmented into public domain registry software and commercial registry software. As per the analysis, the commercial registry software is expected to lead the market in the assessment period. The segment is projected to expand at a CAGR of 9.3% from 2022 to 2032.
The growth of the segment can be attributed to the rapid adoption of electronic health records and various other HCIT solutions in healthcare institutions. Various regulatory bodies are encouraging the adoption of HER solutions to enhance the delivery of healthcare services, which is anticipated to strengthen the segment in the forecast period.
Based on the disease area, the diabetes registry segment is anticipated to dominate the market in the forecast period. The segment is projected to flourish at a CAGR of 9.3% from 2022 to 2032. The growth of the segment can be attributed to the rising number of diabetic patients across the globe. As per the World Health Organization, about 422 million across the globe suffer from diabetes.
An unified Market Research Subscription Platform, built for today’s disparate research needs.
What is the Regional Analysis of the Global Patient Registry Software Market?
How will North America emerge as an Opportunistic Market?
According to the latest reports by FMI, the North American patient registry software market is expected to dominate the market during the forecast period. The analysis reveals that the region is projected to be dominated by the U.S, with a CAGR of 9.5% from 2022 to 2032. U.S is likely to garner US$ 1.5 Billion by 2032.
The growth of the region can be attributed to the expanding target population along with the growing prevalence of diseases. Moreover, favorable initiatives taken by the government are likely to propel the market in the region. Players in the region are taking various efforts to make patient registry software a clinical research-friendly and user interactive software. In August 2019, IQVIA announced a web-based solution for the enlistment of clinical trial information.
Will APAC be an Important Investment Destination for Patient Registry Software Providers?
APAC is anticipated to be the fastest-growing region during the forecast period. As per the analysis, the region is projected to expand at a significant CAGR from 2022 to 2032. China is expected to lead the market, flourishing at a growth rate of 10.5% during the forecast period. Japan is expected to expand at the second-highest CAGR of 9% during the said period of assessment.
On the other hand, India and South Korea have been recognized with some lucrative opportunities. The growing need to eliminate medical errors and increased diagnostics errors are expected to play a significant role in driving the market in the region.
Also, growing awareness about the benefits of EHRs, development in healthcare systems, and rising medical tourism in APAC are other important factors propelling the market in the assessment period. In addition, the implementation of favorable initiatives by the government is expected to augment the market size in the region. In May 2018, the government of South Korea made an investment of US$33.4 Million to develop AI systems that would analyze a patient’s medical registry for better diagnostics. Similarly, in 2019, Fujifilm established FUJIFILM VET Systems in Japan to enhance the adoption of cancer registry software.
|
Country |
Projected CAGR |
|
U.S |
9.5% |
|
Brazil |
9.4% |
|
China |
10.5% |
|
Japan |
9% |
|
Australia |
8.5% |
How Competitive is the Global Patient Registry Software Landscape?
Key players in the global patient registry software market include Dacima Software Inc., Evado eClinical Solutions, IQVIA, Global Vision Technologies Inc., and Invitae. Recent Developments among key players are:
- In March 2021, ESO Solutions announced a strategic partnership with Virginia EMS Systems (US) to provide an EMS data repository and trauma registry across the state.
- In April 2021, IQVIA Holdings accomplished the remaining 40% of Q2 solutions from diagnostic information services providers Quest Diagnostics.
- In December 2020, ImageTrend, Inc. (US) disclosed the latest National Trauma Data Bank (NTDB) Data Dictionary that would be available in the Patient Registry from January 1, 2021.
- In June 2020, ArborMetrix Inc. (US) entered into a strategic partnership with The Society of Interventional Radiology (SIR). The initiative aims to offer the IR Quality Registry to enhance patient care by deploying analytics.
Key Segments Covered in the Patient Registry Software Market Report
Patient Registry Software by Type:
- Public Domain Patient Registry Software
- Commercial Patient Registry Software
Patient Registry Software by Disease Area:
- Diabetes Patient Registry Software
- Cardiovascular Patient Registry Software
- Cancer Patient Registry Software
- Rare Disease/Orphan Disease Patient Registry Software
- Other Chronic Disease Patient Registry Software
Patient Registry Software by End User:
- Patient Registry Software for Governments
- Patient Registry Software for Commercial Use
Patient Registry Software by Region:
- North America Patient Registry Software Market
- Europe Patient Registry Software Market
- Asia Pacific Patient Registry Software Market
- MEA Patient Registry Software Market
- Latin America Patient Registry Software Market
Frequently Asked Questions
The global patient registry software market is anticipated to secure US$ 1.9 Billion in 2022
The expected CAGR of the market is 8.8% from 2022-to-2032
The U.S is projected at US$ 1.5 Billion by 2032 with regard to the patient registry software market.
China is expected to expand at a CAGR of 10.5% from 2022 to 2032
The commercial registry software segment is projected to expand at a CAGR of 8.9% from 2022 to 2032
Japan is anticipated to expand at a CAGR of 9% during the forecast period by 2032.
1. Preface
1.1. Report Description
1.2. Report Scope
1.3. Research Methodology
1.3.1. Primary Research
2. Executive Summary
2.1. Market Snapshot: Global Patient Registry Software Market
2.2. Global Patient Registry Software Market Revenue, 2015– 2032 (US$ Mn) and Y-o-Y Growth (%)
3. Global Patient Registry Software Market Analysis, 2015– 2032 (US$ Mn)
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunities
3.2. Key Trends Analysis
3.3. Global Patient Registry Software Market Analysis, By Type, 2015– 2032 (US$ Mn)
3.3.1. Public Domain Registry Software
3.3.2. Commercial Registry Software
3.4. Global Patient Registry Software Market Analysis, By Disease Areas, 2015– 2032 (US$ Mn)
3.4.1. Diabetes Registry
3.4.2. Cardiovascular Registry
3.4.3. Cancer Registry
3.4.4. Rare Disease/Orphan Disease Registry
3.4.5. Other Chronic Disease Registry
3.5. Global Patient Registry Software Market Analysis, By End-User, 2015– 2032 (US$ Mn)
3.5.1. Government
3.5.2. Commercial
3.6. Competitive Landscape
3.6.1. Market Positioning of Key Players, 2014
3.6.2. Competitive Strategies Adopted by Leading Players
4. North America Patient Registry Software Market Analysis, 2015– 2032 (US$ Mn)
4.1. Key Trends Analysis
4.2. North America Patient Registry Software Market Analysis, By Type, 2015– 2032 (US$ Mn)
4.2.1. Public Domain Registry Software
4.2.2. Commercial Registry Software
4.3. North America Patient Registry Software Market Analysis, By Disease Areas, 2015– 2032 (US$ Mn)
4.3.1. Diabetes Registry
4.3.2. Cardiovascular Registry
4.3.3. Cancer Registry
4.3.4. Rare Disease/Orphan Disease Registry
4.3.5. Other Chronic Disease Registry
4.4. North America Patient Registry Software Market Analysis, By End-User, 2015– 2032 (US$ Mn)
4.4.1. Government
4.4.2. Commercial
4.5. North America Patient Registry Software Market Analysis, By Region, 2015– 2032 (US$ Mn)
4.5.1. U.S.
4.5.2. Rest of North America
5. Europe Patient Registry Software Market Analysis, 2015– 2032 (US$ Mn)
5.1. Key Trends Analysis
5.2. Europe Patient Registry Software Market Analysis, By Type, 2015– 2032 (US$ Mn)
5.2.1. Public Domain Registry Software
5.2.2. Commercial Registry Software
5.3. Europe Patient Registry Software Market Analysis, By Disease Areas, 2015– 2032 (US$ Mn)
5.3.1. Diabetes Registry
5.3.2. Cardiovascular Registry
5.3.3. Cancer Registry
5.3.4. Rare Disease/Orphan Disease Registry
5.3.5. Other Chronic Disease Registry
5.4. Europe Patient Registry Software Market Analysis, By End-User, 2015– 2032 (US$ Mn)
5.4.1. Government
5.4.2. Commercial
5.5. Europe Patient Registry Software Market Analysis, By Region, 2015– 2032 (US$ Mn)
5.5.1. EU7
5.5.2. CIS
5.5.3. Rest of Europe
6. Asia Pacific Patient Registry Software Market Analysis, 2015– 2032 (US$ Mn)
6.1. Key Trends Analysis
6.2. Asia Pacific Patient Registry Software Market Analysis, By Type, 2015– 2032 (US$ Mn)
6.2.1. Public Domain Registry Software
6.2.2. Commercial Registry Software
6.3. Asia Pacific Patient Registry Software Market Analysis, By Disease Areas, 2015– 2032 (US$ Mn)
6.3.1. Diabetes Registry
6.3.2. Cardiovascular Registry
6.3.3. Cancer Registry
6.3.4. Rare Disease/Orphan Disease Registry
6.3.5. Other Chronic Disease Registry
6.4. Asia Pacific Patient Registry Software Market Analysis, By End-User, 2015– 2032 (US$ Mn)
6.4.1. Government
6.4.2. Commercial
6.5. Asia Pacific Patient Registry Software Market Analysis, By Region, 2015– 2032 (US$ Mn)
6.5.1. Japan
6.5.2. China
6.5.3. South Asia
6.5.4. Australasia
6.5.5. Rest of APAC
7. Middle East & Africa (MEA) Patient Registry Software Market Analysis, 2015– 2032 (US$ Mn)
7.1. Key Trends Analysis
7.2. MEA Patient Registry Software Market Analysis, By Type, 2015– 2032 (US$ Mn)
7.2.1. Public Domain Registry Software
7.2.2. Commercial Registry Software
7.3. MEA Patient Registry Software Market Analysis, By Disease Areas, 2015– 2032 (US$ Mn)
7.3.1. Diabetes Registry
7.3.2. Cardiovascular Registry
7.3.3. Cancer Registry
7.3.4. Rare Disease/Orphan Disease Registry
7.3.5. Other Chronic Disease Registry
7.4. MEA Patient Registry Software Market Analysis, By End-User, 2015– 2032 (US$ Mn)
7.4.1. Government
7.4.2. Commercial
7.5. MEA Patient Registry Software Market Analysis, By Region, 2015– 2032 (US$ Mn)
7.5.1. GCC Countries
7.5.2. North Africa
7.5.3. South Africa
7.5.4. Rest of MEA
8. Latin America Patient Registry Software Market Analysis, 2015– 2032 (US$ Mn)
8.1. Key Trends Analysis
8.2. Latin America Patient Registry Software Market Analysis, By Type, 2015– 2032 (US$ Mn)
8.2.1. Public Domain Registry Software
8.2.2. Commercial Registry Software
8.3. Latin America Patient Registry Software Market Analysis, By Disease Areas, 2015– 2032 (US$ Mn)
8.3.1. Diabetes Registry
8.3.2. Cardiovascular Registry
8.3.3. Cancer Registry
8.3.4. Rare Disease/Orphan Disease Registry
8.3.5. Other Chronic Disease Registry
8.4. Latin America Patient Registry Software Market Analysis, By End-User, 2015– 2032 (US$ Mn)
8.4.1. Government
8.4.2. Commercial
8.5. Latin America Patient Registry Software Market Analysis, By Region, 2015– 2032 (US$ Mn)
8.5.1. Brazil
8.5.2. Rest of Latin America
9. Company Profiles
9.1. Global Vision Technologies, Inc.
9.2. IQVIA
9.3. Dacima Software Inc.
9.4. Invitae
9.5. Evado eClinical Solutions
Let us know your requirement to get
100% FREE customization
Table 1: Global Patient Registry Software Market Value (US$ Mn), By Type, 2015 – 2032
Table 2: Global Patient Registry Software Market Value (US$ Mn), By Type, 2022 – 2032
Table 3: Global Patient Registry Software Market Value (US$ Mn), By Disease Area, 2015 – 2032
Table 4: Global Patient Registry Software Market Value (US$ Mn), By Disease Area, 2022 – 2032
Table 5: Global Patient Registry Software Market Value (US$ Mn), By End User, 2015 – 2032
Table 6: Global Patient Registry Software Market Value (US$ Mn), By End User, 2022 – 2032
Table 7: Global Patient Registry Software Market, By Region, 2015 – 2032
Table 8: Global Patient Registry Software Market, By Region, 2022 – 2032
Table 9: North America Patient Registry Software Market Value (US$ Mn), By Type, 2015 – 2032
Table 10: North America Patient Registry Software Market Value (US$ Mn), By Type, 2022 – 2032
Table 11: North America Patient Registry Software Market Value (US$ Mn), By Disease Area, 2015 – 2032
Table 12: North America Patient Registry Software Market Value (US$ Mn), By Disease Area, 2022 – 2032
Table 13: North America Patient Registry Software Market Value (US$ Mn), By End User, 2015 – 2032
Table 14: North America Patient Registry Software Market Value (US$ Mn), By End User, 2022 – 2032
Table 15: North America Patient Registry Software Market, By Country, 2015 – 2032
Table 16: North America Patient Registry Software Market, By Country, 2022 – 2032
Table 17: Latin America Patient Registry Software Market Value (US$ Mn), By Type, 2015 – 2032
Table 18: Latin America Patient Registry Software Market Value (US$ Mn), By Type, 2022 – 2032
Table 19: Latin America Patient Registry Software Market Value (US$ Mn), By Disease Area, 2015 – 2032
Table 20: Latin America Patient Registry Software Market Value (US$ Mn), By Disease Area, 2022 – 2032
Table 21: Latin America Patient Registry Software Market Value (US$ Mn), By End User, 2015 – 2032
Table 22: Latin America Patient Registry Software Market Value (US$ Mn), By End User, 2022 – 2032
Table 23: Latin America Patient Registry Software Market, By Country, 2015 – 2032
Table 24: Latin America Patient Registry Software Market, By Country, 2022 – 2032
Table 25: Europe Patient Registry Software Market Value (US$ Mn), By Type, 2015 – 2032
Table 26: Europe Patient Registry Software Market Value (US$ Mn), By Type, 2022 – 2032
Table 27: Europe Patient Registry Software Market Value (US$ Mn), By Disease Area, 2015 – 2032
Table 28: Europe Patient Registry Software Market Value (US$ Mn), By Disease Area, 2022 – 2032
Table 29: Europe Patient Registry Software Market Value (US$ Mn), By End User, 2015 – 2032
Table 30: Europe Patient Registry Software Market Value (US$ Mn), By End User, 2022 – 2032
Table 31: Europe Patient Registry Software Market, By Country, 2015 – 2032
Table 32: Europe Patient Registry Software Market, By Country, 2022 – 2032
Table 33: Asia Pacific Patient Registry Software Market Value (US$ Mn), By Type, 2015 – 2032
Table 34: Asia Pacific Patient Registry Software Market Value (US$ Mn), By Type, 2022 – 2032
Table 35: Asia Pacific Patient Registry Software Market Value (US$ Mn), By Disease Area, 2015 – 2032
Table 36: Asia Pacific Patient Registry Software Market Value (US$ Mn), By Disease Area, 2022 – 2032
Table 37: Asia Pacific Patient Registry Software Market Value (US$ Mn), By End User, 2015 – 2032
Table 38: Asia Pacific Patient Registry Software Market Value (US$ Mn), By End User, 2022 – 2032
Table 39: Asia Pacific Patient Registry Software Market, By Country, 2015 – 2032
Table 40: Asia Pacific Patient Registry Software Market, By Country, 2022 – 2032
Table 41: MEA Patient Registry Software Market Value (US$ Mn), By Type, 2015 – 2032
Table 42: MEA Patient Registry Software Market Value (US$ Mn), By Type, 2022 – 2032
Table 43: MEA Patient Registry Software Market Value (US$ Mn), By Disease Area, 2015 – 2032
Table 44: MEA Patient Registry Software Market Value (US$ Mn), By Disease Area, 2022 – 2032
Table 45: MEA Patient Registry Software Market Value (US$ Mn), By End User, 2015 – 2032
Table 46: MEA Patient Registry Software Market Value (US$ Mn), By End User, 2022 – 2032
Table 47: MEA Patient Registry Software Market, By Country, 2015 – 2032
Table 48: MEA Patient Registry Software Market, By Country, 2022 – 2032
Table 49: Global Patient Registry Software Market Incremental $ Opportunity, By Type, 2015 – 2032
Table 50: Global Patient Registry Software Market Incremental $ Opportunity, By Disease Area, 2022 – 2032
Table 51: Global Patient Registry Software Market Incremental $ Opportunity, By End User, 2015 – 2032
Table 52: Global Patient Registry Software Market Incremental $ Opportunity, By Region, 2022 – 2032
Table 53: North America Patient Registry Software Market Incremental $ Opportunity, By Type, 2015 – 2032
Table 54: North America Patient Registry Software Market Incremental $ Opportunity, By Disease Area, 2022 – 2032
Table 55: North America Patient Registry Software Market Incremental $ Opportunity, By End User, 2015 – 2032
Table 56: North America Patient Registry Software Market Incremental $ Opportunity, By Country, 2022 – 2032
Table 57: Latin America Patient Registry Software Market Incremental $ Opportunity, By Type, 2015 – 2032
Table 58: Latin America Patient Registry Software Market Incremental $ Opportunity, By Disease Area, 2022 – 2032
Table 59: Latin America Patient Registry Software Market Incremental $ Opportunity, By End User, 2015 – 2032
Table 60: Latin America Patient Registry Software Market Incremental $ Opportunity, By Country, 2022 – 2032
Table 61: Europe Patient Registry Software Market Incremental $ Opportunity, By Type, 2015 – 2032
Table 62: Europe Patient Registry Software Market Incremental $ Opportunity, By Disease Area, 2022 – 2032
Table 63: Europe Patient Registry Software Market Incremental $ Opportunity, By End User, 2015 – 2032
Table 64: Europe Patient Registry Software Market Incremental $ Opportunity, By Country, 2015 - 2032
Table 65: Asia Pacific Patient Registry Software Market Incremental $ Opportunity, By Type, 2015 – 2032
Table 66: Asia Pacific Patient Registry Software Market Incremental $ Opportunity, By Disease Area, 2022 – 2032
Table 67: Asia Pacific Patient Registry Software Market Incremental $ Opportunity, By End User, 2015 – 2032
Table 68: Asia Pacific Patient Registry Software Market Incremental $ Opportunity, By Country, 2022 – 2032
Table 69: MEA Patient Registry Software Market Incremental $ Opportunity, By Type, 2015 – 2032
Table 70: MEA Patient Registry Software Market Incremental $ Opportunity, By Disease Area, 2022 – 2032
Table 71: MEA Patient Registry Software Market Incremental $ Opportunity, By End User, 2015 – 2032
Table 72: MEA Patient Registry Software Market Incremental $ Opportunity, By Country, 2015 - 2032
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystFigure 1: Global Patient Registry Software Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 2: Global Patient Registry Software Market Absolute $ Historical Gain (2015 – 2032) and Opportunity (2015 -2032), US$ Mn
Figure 3: Global Patient Registry Software Market Share, by Type, 2021 & 2032
Figure 4: Global Patient Registry Software Market Y-o-Y Growth Projections, Type – 2015 -2032
Figure 5: Global Patient Registry Software Market Attractiveness Index, Type – 2015 -2032
Figure 6: Global Patient Registry Software Market Share, By Disease Area, 2021 & 2032
Figure 7: Global Patient Registry Software Market Y-o-Y Growth Projections, By Disease Area– 2015 -2032
Figure 8: Global Patient Registry Software Market Attractiveness Index, By Disease Area– 2015 -2032
Figure 9: Global Patient Registry Software Market Share, By End User, 2021 & 2032
Figure 10: Global Patient Registry Software Market Y-o-Y Growth Projections, By End User – 2015 -2032
Figure 11: Global Patient Registry Software Market Attractiveness Index, By End User – 2015 -2032
Figure 12: Global Patient Registry Software Market Share, By Region, 2021 & 2032
Figure 13: Global Patient Registry Software Market Y-o-Y Growth Projections, By Region – 2015 -2032
Figure 14: Global Patient Registry Software Market Attractiveness Index, By Region – 2015 -2032
Figure 15: North America Patient Registry Software Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 16: North America Patient Registry Software Market Absolute $ Opportunity Historical (2015 – 2032) and Forecast Period (2015 -2032), US$ Mn
Figure 17: North America Patient Registry Software Market Share, Type, 2021 & 2032
Figure 18: North America Patient Registry Software Market Y-o-Y Growth Projections, Type – 2015 -2032
Figure 19: North America Patient Registry Software Market Attractiveness Index, Type – 2015 -2032
Figure 20: North America Patient Registry Software Market Share, By Disease Area, 2021 & 2032
Figure 21: North America Patient Registry Software Market Y-o-Y Growth Projections, By Disease Area– 2015 -2032
Figure 22: North America Patient Registry Software Market Attractiveness Index, By Disease Area– 2015 -2032
Figure 23: North America Patient Registry Software Market Share, By End User, 2021 & 2032
Figure 24: North America Patient Registry Software Market Y-o-Y Growth Projections, By End User – 2015 -2032
Figure 25: North America Patient Registry Software Market Attractiveness Index, By End User – 2015 -2032
Figure 26: North America Patient Registry Software Market Share, By Country, 2021 & 2032
Figure 27: North America Market Y-o-Y Growth Projections, By Country – 2015 -2032
Figure 28: North America Market Attractiveness Index, By Country – 2015 -2032
Figure 29: Latin America Patient Registry Software Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 30: Latin America Patient Registry Software Market Absolute $ Opportunity Historical (2015 – 2032) and Forecast Period (2015 -2032), US$ Mn
Figure 31: Latin America Patient Registry Software Market Share, Type, 2021 & 2032
Figure 32: Latin America Patient Registry Software Market Y-o-Y Growth Projections, Type – 2015 -2032
Figure 33: Latin America Patient Registry Software Market Attractiveness Index, Type – 2015 -2032
Figure 34: Latin America Patient Registry Software Market Share, By Disease Area, 2021 & 2032
Figure 35: Latin America Patient Registry Software Market Y-o-Y Growth Projections, By Disease Area– 2015 -2032
Figure 36: Latin America Patient Registry Software Market Attractiveness Index, By Disease Area– 2015 -2032
Figure 37: Latin America Patient Registry Software Market Share, By End User, 2021 & 2032
Figure 38: Latin America Patient Registry Software Market Y-o-Y Growth Projections, By End User – 2015 -2032
Figure 39: Latin America Patient Registry Software Market Attractiveness Index, By End User – 2015 -2032
Figure 40: Latin America Patient Registry Software Market Share, By Country, 2021 & 2032
Figure 41: Latin America Patient Registry Software Market Y-o-Y Growth Projections, By Country – 2015 -2032
Figure 42: Latin America Patient Registry Software Market Attractiveness Index, By Country – 2015 -2032
Figure 43: Europe Patient Registry Software Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 44: Europe Patient Registry Software Market Absolute $ Opportunity Historical (2015 – 2032) and Forecast Period (2015 -2032), US$ Mn
Figure 45: Europe Patient Registry Software Market Share, Type, 2021 & 2032
Figure 46: Europe Patient Registry Software Market Y-o-Y Growth Projections, Type – 2015 -2032
Figure 47: Europe Patient Registry Software Market Attractiveness Index, Type – 2015 -2032
Figure 48: Europe Patient Registry Software Market Share, By Disease Area, 2021 & 2032
Figure 49: Europe Patient Registry Software Market Y-o-Y Growth Projections, By Disease Area– 2015 -2032
Figure 50: Europe Patient Registry Software Market Attractiveness Index, By Disease Area– 2015 -2032
Figure 51: Europe Patient Registry Software Market Share, By End User, 2021 & 2032
Figure 52: Europe Patient Registry Software Market Y-o-Y Growth Projections, By End User – 2015 -2032
Figure 53: Europe Patient Registry Software Market Attractiveness Index, By End User – 2015 -2032
Figure 54: Europe Patient Registry Software Market Share, By Country, 2021 & 2032
Figure 55: Europe Patient Registry Software Market Y-o-Y Growth Projections, By Country – 2015 -2032
Figure 56: Europe Patient Registry Software Market Attractiveness Index, By Country – 2015 -2032
Figure 57: MEA Patient Registry Software Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 58: MEA Patient Registry Software Market Absolute $ Opportunity Historical (2015 – 2032) and Forecast Period (2015 -2032), US$ Mn
Figure 59: MEA Patient Registry Software Market Share, Type, 2021 & 2032
Figure 60: MEA Patient Registry Software Market Y-o-Y Growth Projections, Type – 2015 -2032
Figure 61: MEA Patient Registry Software Market Attractiveness Index, Type – 2015 -2032
Figure 62: MEA Patient Registry Software Market Share, By Disease Area, 2021 & 2032
Figure 63: MEA Patient Registry Software Market Y-o-Y Growth Projections, By Disease Area– 2015 -2032
Figure 64: MEA Patient Registry Software Market Attractiveness Index, By Disease Area– 2015 -2032
Figure 65: MEA Patient Registry Software Market Share, By End User, 2021 & 2032
Figure 66: MEA Patient Registry Software Market Y-o-Y Growth Projections, By End User – 2015 -2032
Figure 67: MEA Patient Registry Software Market Attractiveness Index, By End User – 2015 -2032
Figure 68: MEA Patient Registry Software Market Share, By Country, 2021 & 2032
Figure 69: MEA Patient Registry Software Market Y-o-Y Growth Projections, By Country – 2015 -2032
Figure 70: MEA Patient Registry Software Market Attractiveness Index, By Country – 2015 -2032
Figure 71: Asia Pacific Patient Registry Software Market Value (US$ Mn) and Year-on-Year Growth, 2015 – 2032
Figure 72: Asia Pacific Patient Registry Software Market Absolute $ Opportunity Historical (2015 – 2032) and Forecast Period (2015 -2032), US$ Mn
Figure 73: Asia Pacific Patient Registry Software Market Share, Type, 2021 & 2032
Figure 74: Asia Pacific Patient Registry Software Market Y-o-Y Growth Projections, Type – 2015 -2032
Figure 75: Asia Pacific Patient Registry Software Market Attractiveness Index, Type – 2015 -2032
Figure 76: Asia Pacific Patient Registry Software Market Share, By Disease Area, 2021 & 2032
Figure 77: Asia Pacific Patient Registry Software Market Y-o-Y Growth Projections, By Disease Area– 2015 -2032
Figure 78: Asia Pacific Patient Registry Software Market Attractiveness Index, By Disease Area– 2015 -2032
Figure 79: Asia Pacific Patient Registry Software Market Share, By End User, 2021 & 2032
Figure 80: Asia Pacific Patient Registry Software Market Y-o-Y Growth Projections, By End User – 2015 -2032
Figure 81: Asia Pacific Patient Registry Software Market Attractiveness Index, By End User – 2015 -2032
Figure 82: Asia Pacific Patient Registry Software Market Share, By Country, 2021 & 2032
Figure 83: Asia Pacific Patient Registry Software Market Y-o-Y Growth Projections, By Country – 2015 -2032
Figure 84: Asia Pacific Patient Registry Software Market Attractiveness Index, By Country – 2015 -2032
Figure 67 : US Patient Engagement Solutions Market Value (US$ Mn) and Forecast, 2015-2032
Figure 68 : US Patient Engagement Solutions Market Share, Delivery Mode, 2021 & 2032
Figure 69 : US Patient Engagement Solutions Market Share, By End User, 2021 & 2032
Figure 70 : Rest of North America Patient Engagement Solutions Market Value (US$ Mn) and Forecast, 2015-2032
Figure 71 : Rest of North America Patient Engagement Solutions Market Share, Delivery Mode, 2021 & 2032
Figure 72 : Rest of North America Patient Engagement Solutions Market Share, By End User, 2021 & 2032
Figure 73 : EU7 Patient Engagement Solutions Market Value (US$ Mn) and Forecast, 2015-2032
Figure 74 : EU7 Patient Engagement Solutions Market Share, Delivery Mode, 2021 & 2032
Figure 75 : EU7 Patient Engagement Solutions Market Share, By End User, 2021 & 2032
Figure 76 : CIS Patient Engagement Solutions Market Value (US$ Mn) and Forecast, 2015-2032
Figure 77 : CIS Patient Engagement Solutions Market Share, Delivery Mode, 2021 & 2032
Figure 78 : CIS Patient Engagement Solutions Market Share, By End User, 2021 & 2032
Figure 79 : Rest of Europe Patient Engagement Solutions Market Value (US$ Mn) and Forecast, 2015-2032
Figure 80 : Rest of Europe Patient Engagement Solutions Market Share, Delivery Mode, 2021 & 2032
Figure 81 : Rest of Europe Patient Engagement Solutions Market Share, By End User, 2021 & 2032
Figure 82 : GCC Countries Patient Engagement Solutions Market Value (US$ Mn) and Forecast, 2015-2032
Figure 83 : GCC Countries Patient Engagement Solutions Market Share, Delivery Mode, 2021 & 2032
Figure 84 : GCC Countries Patient Engagement Solutions Market Share, By End User, 2021 & 2032
Figure 85 : North Africa Patient Engagement Solutions Market Value (US$ Mn) and Forecast, 2015-2032
Figure 86 : North Africa Patient Engagement Solutions Market Share, Delivery Mode, 2021 & 2032
Figure 87 : North Africa Patient Engagement Solutions Market Share, By End User, 2021 & 2032
Figure 88 : South Africa Patient Engagement Solutions Market Value (US$ Mn) and Forecast, 2015-2032
Figure 89 : South Africa Patient Engagement Solutions Market Share, Delivery Mode, 2021 & 2032
Figure 90 : South Africa Patient Engagement Solutions Market Share, By End User, 2021 & 2032
Figure 91 : Rest of MEA Patient Engagement Solutions Market Value (US$ Mn) and Forecast, 2015-2032
Figure 92 : Rest of MEA Patient Engagement Solutions Market Share, Delivery Mode, 2021 & 2032
Figure 93 : Rest of MEA Patient Engagement Solutions Market Share, By End User, 2021 & 2032
Figure 94 : Brazil Patient Engagement Solutions Market Value (US$ Mn) and Forecast, 2015-2032
Figure 95 : Brazil Patient Engagement Solutions Market Share, Delivery Mode, 2021 & 2032
Figure 96 : Brazil Patient Engagement Solutions Market Share, By End User, 2021 & 2032
Figure 97 : Rest of Latin America Patient Engagement Solutions Market Value (US$ Mn) and Forecast, 2015-2032
Figure 98 : Rest of Latin America Patient Engagement Solutions Market Share, Delivery Mode, 2021 & 2032
Figure 99 : Rest of Latin America Patient Engagement Solutions Market Share, By End User, 2021 & 2032
Figure 100 : China Patient Engagement Solutions Market Value (US$ Mn) and Forecast, 2015-2032
Figure 101 : China Patient Engagement Solutions Market Share, Delivery Mode, 2021 & 2032
Figure 102 : China Patient Engagement Solutions Market Share, By End User, 2021 & 2032
Figure 103 : Japan Patient Engagement Solutions Market Value (US$ Mn) and Forecast, 2015-2032
Figure 104 : Japan Patient Engagement Solutions Market Share, Delivery Mode, 2021 & 2032
Figure 105 : Japan Patient Engagement Solutions Market Share, By End User, 2021 & 2032
Figure 106 : South Asia Patient Engagement Solutions Market Value (US$ Mn) and Forecast, 2015-2032
Figure 107 : South Asia Patient Engagement Solutions Market Share, Delivery Mode, 2021 & 2032
Figure 108 : South Asia Patient Engagement Solutions Market Share, By End User, 2021 & 2032
Figure 109 : Australasia Patient Engagement Solutions Market Value (US$ Mn) and Forecast, 2015-2032
Figure 110: Australasia Patient Engagement Solutions Market Share, Delivery Mode, 2021 & 2032
Figure 111: Australasia Patient Engagement Solutions Market Share, By End User, 2021 & 2032
Figure 112 : Rest of APAC Patient Engagement Solutions Market Value (US$ Mn) and Forecast, 2015-2032
Figure 113 : Rest of APAC Patient Engagement Solutions Market Share, Delivery Mode, 2021 & 2032
Figure 114 : Rest of APAC Patient Engagement Solutions Market Share, By End User, 2021 & 2032
Need specific information?
Request CustomizationExplore Technology Insights
View Reports
